VIR · Vir Biotechnology, Inc. · Documents
$11.75
+0.18 (+1.51%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$1.88B
Shares
169.22M
Volume · Oct 28
583.06K
Avg daily vol (3M)
1.91M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEFA14A | — | 2024-05-14 | — | |
| 10-Q | — | 2024-05-03 | 2024-03-31 | |
| 8-K | — | 2024-05-02 | — | |
| DEFA14A | — | 2024-04-19 | — | |
| ARS | — | 2024-04-19 | 2023-12-31 | |
| DEF 14A | — | 2024-04-19 | 2024-05-29 | |
| 8-K | — | 2024-04-18 | 2024-04-15 | |
| 10-K | — | 2024-02-26 | 2023-12-31 | |
| 8-K | — | 2024-02-22 | 2024-02-21 | |
| 8-K | — | 2024-02-20 | 2024-02-19 | |
| 8-K | — | 2023-12-13 | — | |
| S-3ASR | — | 2023-11-03 | — | |
| 10-Q | — | 2023-11-03 | 2023-09-30 | |
| 8-K | — | 2023-11-03 | — | |
| 8-K | — | 2023-11-02 | — | |
| 8-K | — | 2023-10-03 | — | |
| 8-K | — | 2023-09-20 | 2023-09-19 | |
| 10-Q | — | 2023-08-04 | 2023-06-30 | |
| 8-K | — | 2023-08-03 | — | |
| 8-K | — | 2023-07-20 | — | |
| 8-K | — | 2023-05-23 | 2023-05-19 | |
| 10-Q | — | 2023-05-08 | 2023-03-31 | |
| 8-K | — | 2023-05-04 | — | |
| DEFA14A | — | 2023-04-07 | — | |
| DEF 14A | — | 2023-04-07 | — | |
| ARS | — | 2023-04-07 | 2022-12-31 | |
| 8-K | — | 2023-03-13 | 2023-03-10 | |
| 8-K | — | 2023-03-08 | 2023-03-02 | |
| 10-K | — | 2023-02-28 | 2022-12-31 | |
| 8-K | — | 2023-02-23 | — | |
| 8-K | — | 2023-02-22 | 2023-02-21 | |
| 8-K | — | 2023-02-16 | 2023-02-13 | |
| 8-K | — | 2023-02-13 | 2023-02-08 | |
| 8-K | — | 2023-01-25 | 2023-01-19 | |
| 10-Q | — | 2022-11-03 | 2022-09-30 | |
| 8-K | — | 2022-11-03 | — | |
| 8-K | — | 2022-10-04 | 2022-09-28 | |
| 8-K | — | 2022-08-09 | — | |
| 10-Q | — | 2022-08-09 | 2022-06-30 | |
| 8-K | — | 2022-08-04 | — | |
| 8-K | — | 2022-07-14 | 2022-07-11 | |
| 8-K | — | 2022-06-03 | 2022-05-27 | |
| 8-K | — | 2022-05-24 | 2022-05-20 | |
| 8-K | — | 2022-05-20 | 2022-05-16 | |
| 8-K | — | 2022-05-05 | — | |
| 10-Q | — | 2022-05-05 | 2022-03-31 | |
| 8-K | — | 2022-04-07 | 2022-04-04 | |
| DEFA14A | — | 2022-04-07 | — | |
| DEF 14A | — | 2022-04-07 | 2022-05-20 | |
| 8-K | — | 2022-04-05 | — |
Showing 51–100 of 157 filings
Key facts
CIK
1706431
CUSIP
92764N102
13F (30d)
43 filings
43 filers
Visit website
Investor relations